Biogen Inc. buy Needham & Company LLC
Start price
01.08.24
/
50%
€198.10
Target price
01.08.25
€266.57
Performance (%)
-42.66%
End price
02.08.25
€113.60
Summary
This prediction ended on 02.08.25 with a price of €113.60. The BUY prediction by Needham___Company_LL for Biogen Inc. performed very badly with a performance of -42.66%. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -4.751% | -4.751% | 3.814% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Needham___Company_LL for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $288.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten